Oncology

Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer.

Showing 1–12 of 76 results

Filter our product list:
API
Antigen / Target
Therapeutic Areas
1
Therapeutic Indications
Classes of molecule​s
Isotypes
Expiry Date
CoA
Filters Sort results
Reset Apply

Product
Batch

Antigen
Molecular Class
Drug Brand
Product Concentration
CoA
Quantity per vial
Storage Temperature
Expiry Date
Price from
FRɑ
Antibody-drug conjugate (ADC)
Elahere®
5 mg/mL
2 mg
tba
tba
1.817,00 
view product
Max: 10
Min: 8
Step: 1
CCR4
Monoclonal Antibody
Poteligeo®
4 mg/mL
0,5 mg
-80 °C
09/2023
312,30 
view product
Max: 10
Min: 1
Step: 1
CD20
,
CD3
Bispecific Antibody
Lunsumio®
1 mg/mL
0.05 mg
tba
tba
316,00 
view product
Max: 10
Min: 7
Step: 1
CD20
Monoclonal Antibody
Gazyvaro®
25 mg/mL
6 mg
-80°C
06/2019
279,90 
view product
Max: 10
Min: 1
Step: 1
CD20
Monoclonal Antibody
Gazyvaro®
25 mg/mL
6 mg
-80°C
08/2019
279,90 
view product
Max: 10
Min: 1
Step: 1
EGFR
Monoclonal Antibody
Vectibix®
20 mg/mL
2 mg
-80 °C
02/2025
230,00 
view product
Max: 28
Min: 2
Step: 1
HER2
Monoclonal Antibody
Perjeta®
30 mg/mL
yes
6 mg
-80°C
11/2020
419,40 
view product
Max: 10
Min: 1
Step: 1
HER2
Monoclonal Antibody
Phesgo®
60 mg/mL
12 mg
tba
tba
717,00 
view product
Max:
Min: 8
Step: 1
CD79b
Antibody-drug conjugate (ADC)
Polivy®
20 mg/mL
1 mg
-80 °C
06/2024
536,00 
view product
Max: 9
Min: 1
Step: 1
VEGFR2
Monoclonal Antibody
Cyramza®
10 mg/mL
2 mg
-80°C
03/2018
182,70 
view product
Max: 10
Min: 2
Step: 1
VEGFR2
Monoclonal Antibody
Cyramza®
10 mg/mL
2 mg
-80°C
06/2018
182,70 
view product
Max: 10
Min: 2
Step: 1
VEGFR2
Monoclonal Antibody
Cyramza®
10 mg/mL
2 mg
-80°C
08/2018
182,70 
view product
Max: 10
Min: 2
Step: 1
VEGFR2
Monoclonal Antibody
Cyramza®
10 mg/mL
2 mg
-80°C
01/2019
182,70 
view product
Max: 10
Min: 2
Step: 1
VEGFR2
Monoclonal Antibody
Cyramza®
10 mg/mL
2 mg
-80°C
12/2019
182,70 
view product
Max: 10
Min: 2
Step: 1
VEGFR2
Monoclonal Antibody
Cyramza®
10 mg/mL
2 mg
-80°C
06/2020
182,70 
view product
Max: 8
Min: 2
Step: 1
CD20
Biosimilar
,
Monoclonal Antibody
Ruxience®
10 mg/mL
2 mg
tba
tba
196,00 
view product
Max:
Min: 11
Step: 1
CD20
Biosimilar
,
Monoclonal Antibody
Truxima®
10 mg/mL
2 mg
tba
tba
234,00 
view product
Max:
Min: 10
Step: 1
CD20
Monoclonal Antibody
MabThera®
10 mg/mL
2 mg
-80°C
05/2018
126,90 
view product
Max: 10
Min: 3
Step: 1
CD20
Monoclonal Antibody
MabThera®
10 mg/mL
2 mg
-80°C
09/2018
126,90 
view product
Max: 10
Min: 3
Step: 1
CD20
Monoclonal Antibody
MabThera®
10 mg/mL
2 mg
-80°C
12/2018
126,90 
view product
Max: 10
Min: 3
Step: 1
CD20
Monoclonal Antibody
MabThera®
10 mg/mL
2 mg
-80°C
02/2019
126,90 
view product
Max: 10
Min: 3
Step: 1
CD20
Monoclonal Antibody
MabThera®
10 mg/mL
2 mg
-80°C
02/2019
126,90 
view product
Max: 10
Min: 3
Step: 1
CD20
Monoclonal Antibody
MabThera®
10 mg/mL
2 mg
-80°C
08/2019
126,90 
view product
Max: 10
Min: 3
Step: 1
CD20
Monoclonal Antibody
MabThera®
10 mg/mL
2 mg
-80°C
12/2019
126,90 
view product
Max: 10
Min: 3
Step: 1
CD20
Monoclonal Antibody
MabThera®
10 mg/mL
2 mg
-80°C
07/2021
126,90 
view product
Max: 10
Min: 3
Step: 1
CD20
Biosimilar
,
Monoclonal Antibody
Rixathon®
10 mg/mL
2 mg
-80 °C
03/2026
311,00 
view product
Max: 10
Min: 2
Step: 1
Trop-2-directed ADC
Antibody-drug conjugate (ADC)
Trodelvy®
10 mg/mL
4 mg
-80°C
08/2025
299,00 
view product
Max: 10
Min: 1
Step: 1
CD3
,
TCR targeting domain
Bispecific fusion protein
Kimmtrak®
0,2 mg/mL
0.01 mg
tba
tba
4.602,00 
view product
Max:
Min: 4
Step: 1
B cell maturation antigen
,
CD3
Bispecific Antibody
Tecvayli®
10 mg/mL
0,5 mg
tba
tba
303,00 
view product
Max: 20
Min: 10
Step: 1
Tissue factor (TF)
Antibody-drug conjugate (ADC)
Tivdak®
10 mg/mL
1 mg
tba
tba
1.665,00 
view product
Max: 10
Min: 7
Step: 1
1 2 3

Not looking for Oncology?

Search our therapeutic molecules product database